{"podcast":{"title":"Neuro-Oncology: The Podcast","slug":"neuro-oncology-the-podcast-1565653","podcast_index_feed_id":1565653,"rss_url":"https://soc-neuro-onc.libsyn.com/rss","website_url":"https://soc-neuro-onc.libsyn.com","image_url":"https://static.libsyn.com/p/assets/e/f/5/2/ef52e509e1640133/Neuro-oncology_Podcast_G2b.jpg","author":"Neuro-Oncology","episode_count":146,"summary":"Neuro-Oncology: The Podcast will keep you up to date about the latest advances in the field as we present conversations with the authors of selected papers from Neuro-Oncology and its sister journals, Neuro-Oncology Practice and Neuro-Oncology Advances.","last_synced_at":"2026-07-24T20:19:44.205313+00:00","page_url":"https://stenobird.com/podcast/neuro-oncology-the-podcast-1565653"},"episodes":[{"title":"Hot Topics: Integrative Neuro-Oncology","slug":"hot-topics-integrative-neuro-oncology","published_at":"2026-07-24T10:00:00+00:00","page_url":"https://stenobird.com/podcast/neuro-oncology-the-podcast-1565653/hot-topics-integrative-neuro-oncology","url":"https://soc-neuro-onc.libsyn.com/hot-topics-integrative-neuro-oncology","duration_seconds":1859,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/neuro-oncology-the-podcast-1565653/episodes/hot-topics-integrative-neuro-oncology/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/neuro-oncology-the-podcast-1565653/hot-topics-integrative-neuro-oncology.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"SNOBound: Career Advice with Dr. Justin Lathia","slug":"snobound-career-advice-with-dr-justin-lathia","published_at":"2026-07-10T09:00:00+00:00","page_url":"https://stenobird.com/podcast/neuro-oncology-the-podcast-1565653/snobound-career-advice-with-dr-justin-lathia","url":"https://soc-neuro-onc.libsyn.com/snobound-career-advice-with-dr-justin-lathia","duration_seconds":1053,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/neuro-oncology-the-podcast-1565653/episodes/snobound-career-advice-with-dr-justin-lathia/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/neuro-oncology-the-podcast-1565653/snobound-career-advice-with-dr-justin-lathia.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Author Interviews: cIMPACT-NOW update 12: Refining Pathology-based Risk Stratification and Grading for IDH-mutant Gliomas","slug":"author-interviews-cimpact-now-update-12-refining-pathology-based-risk-stratification-and-grading-for-idh-mutant-gliomas","published_at":"2026-07-06T09:00:00+00:00","page_url":"https://stenobird.com/podcast/neuro-oncology-the-podcast-1565653/author-interviews-cimpact-now-update-12-refining-pathology-based-risk-stratification-and-grading-for-idh-mutant-gliomas","url":"https://soc-neuro-onc.libsyn.com/author-interviews-cimpact-now-update-12-refining-pathology-based-risk-stratification-and-grading-for-idh-mutant-gliomas","duration_seconds":1692,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/neuro-oncology-the-podcast-1565653/episodes/author-interviews-cimpact-now-update-12-refining-pathology-based-risk-stratification-and-grading-for-idh-mutant-gliomas/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/neuro-oncology-the-podcast-1565653/author-interviews-cimpact-now-update-12-refining-pathology-based-risk-stratification-and-grading-for-idh-mutant-gliomas.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"A Conversation on Career Journeys with SNO's Young Investigator Committee Chairs","slug":"a-conversation-on-career-journeys-with-sno-s-young-investigator-committee-chairs","published_at":"2026-06-26T09:00:00+00:00","page_url":"https://stenobird.com/podcast/neuro-oncology-the-podcast-1565653/a-conversation-on-career-journeys-with-sno-s-young-investigator-committee-chairs","url":"https://soc-neuro-onc.libsyn.com/a-conversation-on-career-journeys-with-snos-young-investigator-committee-chairs","duration_seconds":1762,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/neuro-oncology-the-podcast-1565653/episodes/a-conversation-on-career-journeys-with-sno-s-young-investigator-committee-chairs/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/neuro-oncology-the-podcast-1565653/a-conversation-on-career-journeys-with-sno-s-young-investigator-committee-chairs.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Neuro-onc Narratives: Two Insiders, One Diagnosis: A Neurosurgeon and Healthcare Leader on Living with GBM","slug":"neuro-onc-narratives-two-insiders-one-diagnosis-a-neurosurgeon-and-healthcare-leader-on-living-with-gbm","published_at":"2026-06-19T09:00:00+00:00","page_url":"https://stenobird.com/podcast/neuro-oncology-the-podcast-1565653/neuro-onc-narratives-two-insiders-one-diagnosis-a-neurosurgeon-and-healthcare-leader-on-living-with-gbm","url":"https://soc-neuro-onc.libsyn.com/neuro-onc-narratives-two-insiders-one-diagnosis-a-neurosurgeon-and-healthcare-leader-on-living-with-gbm","duration_seconds":2347,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/neuro-oncology-the-podcast-1565653/episodes/neuro-onc-narratives-two-insiders-one-diagnosis-a-neurosurgeon-and-healthcare-leader-on-living-with-gbm/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/neuro-oncology-the-podcast-1565653/neuro-onc-narratives-two-insiders-one-diagnosis-a-neurosurgeon-and-healthcare-leader-on-living-with-gbm.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Ivosidenib in predominantly recurrent IDH1-mutant glioma: A single-institution experience","slug":"ivosidenib-in-predominantly-recurrent-idh1-mutant-glioma-a-single-institution-experience","published_at":"2026-06-15T09:00:00+00:00","page_url":"https://stenobird.com/podcast/neuro-oncology-the-podcast-1565653/ivosidenib-in-predominantly-recurrent-idh1-mutant-glioma-a-single-institution-experience","url":"https://soc-neuro-onc.libsyn.com/ivosidenib-in-predominantly-recurrent-idh1-mutant-glioma-a-single-institution-experience","duration_seconds":972,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/neuro-oncology-the-podcast-1565653/episodes/ivosidenib-in-predominantly-recurrent-idh1-mutant-glioma-a-single-institution-experience/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/neuro-oncology-the-podcast-1565653/ivosidenib-in-predominantly-recurrent-idh1-mutant-glioma-a-single-institution-experience.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Author Interview: Prospective biopsy-controlled validation of an AI model for predicting glioblastoma infiltration: Results from the SupraGlio trial","slug":"author-interview-prospective-biopsy-controlled-validation-of-an-ai-model-for-predicting-glioblastoma-infiltration-results-from-the-supraglio-trial","published_at":"2026-06-01T10:00:00+00:00","page_url":"https://stenobird.com/podcast/neuro-oncology-the-podcast-1565653/author-interview-prospective-biopsy-controlled-validation-of-an-ai-model-for-predicting-glioblastoma-infiltration-results-from-the-supraglio-trial","url":"https://soc-neuro-onc.libsyn.com/oauthor-interviews-prospective-biopsy-controlled-validation-of-an-ai-model-for-predicting-glioblastoma-infiltration-results-from-the-supraglio-trial","duration_seconds":1759,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/neuro-oncology-the-podcast-1565653/episodes/author-interview-prospective-biopsy-controlled-validation-of-an-ai-model-for-predicting-glioblastoma-infiltration-results-from-the-supraglio-trial/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/neuro-oncology-the-podcast-1565653/author-interview-prospective-biopsy-controlled-validation-of-an-ai-model-for-predicting-glioblastoma-infiltration-results-from-the-supraglio-trial.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Neuro-Oncology Nugget: GT-20 Phase 1 Trial — Personalized Neoantigen DNA Vaccine for MGMT Unmethylated Glioblastoma","slug":"neuro-oncology-nugget-gt-20-phase-1-trial-personalized-neoantigen-dna-vaccine-for-mgmt-unmethylated-glioblastoma","published_at":"2026-05-30T03:03:00+00:00","page_url":"https://stenobird.com/podcast/neuro-oncology-the-podcast-1565653/neuro-oncology-nugget-gt-20-phase-1-trial-personalized-neoantigen-dna-vaccine-for-mgmt-unmethylated-glioblastoma","url":"https://soc-neuro-onc.libsyn.com/neuro-oncology-nugget-gt-20-phase-1-trial-personalized-neoantigen-dna-vaccine-for-mgmt-unmethylated-glioblastoma","duration_seconds":199,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/neuro-oncology-the-podcast-1565653/episodes/neuro-oncology-nugget-gt-20-phase-1-trial-personalized-neoantigen-dna-vaccine-for-mgmt-unmethylated-glioblastoma/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/neuro-oncology-the-podcast-1565653/neuro-oncology-nugget-gt-20-phase-1-trial-personalized-neoantigen-dna-vaccine-for-mgmt-unmethylated-glioblastoma.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Author Interview Series SNO Podcast May 2026","slug":"author-interview-series-sno-podcast-may-2026","published_at":"2026-05-25T10:00:00+00:00","page_url":"https://stenobird.com/podcast/neuro-oncology-the-podcast-1565653/author-interview-series-sno-podcast-may-2026","url":"https://soc-neuro-onc.libsyn.com/author-interview-series-sno-podcast-may-2026","duration_seconds":983,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/neuro-oncology-the-podcast-1565653/episodes/author-interview-series-sno-podcast-may-2026/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/neuro-oncology-the-podcast-1565653/author-interview-series-sno-podcast-may-2026.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Neuro-Oncology Narrative","slug":"neuro-oncology-narrative","published_at":"2026-05-18T10:00:00+00:00","page_url":"https://stenobird.com/podcast/neuro-oncology-the-podcast-1565653/neuro-oncology-narrative","url":"https://soc-neuro-onc.libsyn.com/neuro-oncology-narrative","duration_seconds":2066,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/neuro-oncology-the-podcast-1565653/episodes/neuro-oncology-narrative/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/neuro-oncology-the-podcast-1565653/neuro-oncology-narrative.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Hot Topics: Wellness in Neuro-oncology","slug":"hot-topics-wellness-in-neuro-oncology","published_at":"2026-05-15T10:00:00+00:00","page_url":"https://stenobird.com/podcast/neuro-oncology-the-podcast-1565653/hot-topics-wellness-in-neuro-oncology","url":"https://soc-neuro-onc.libsyn.com/hot-topics-wellness-in-neuro-oncology","duration_seconds":1477,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/neuro-oncology-the-podcast-1565653/episodes/hot-topics-wellness-in-neuro-oncology/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/neuro-oncology-the-podcast-1565653/hot-topics-wellness-in-neuro-oncology.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Neuro-Oncology Nugget: Phase 1/2 BT008NA Trial — Focused Ultrasound + Temozolomide for High-Grade Glioma","slug":"neuro-oncology-nugget-phase-1-2-bt008na-trial-focused-ultrasound-temozolomide-for-high-grade-glioma","published_at":"2026-05-11T09:00:00+00:00","page_url":"https://stenobird.com/podcast/neuro-oncology-the-podcast-1565653/neuro-oncology-nugget-phase-1-2-bt008na-trial-focused-ultrasound-temozolomide-for-high-grade-glioma","url":"https://soc-neuro-onc.libsyn.com/neuro-oncology-nugget-phase-12-bt008na-trial-focused-ultrasound-temozolomide-for-high-grade-glioma","duration_seconds":236,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/neuro-oncology-the-podcast-1565653/episodes/neuro-oncology-nugget-phase-1-2-bt008na-trial-focused-ultrasound-temozolomide-for-high-grade-glioma/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/neuro-oncology-the-podcast-1565653/neuro-oncology-nugget-phase-1-2-bt008na-trial-focused-ultrasound-temozolomide-for-high-grade-glioma.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"SNObound: Career description and advice from Dr. Ryan Cecchi in Neuropathology","slug":"snobound-career-description-and-advice-from-dr-ryan-cecchi-in-neuropathology","published_at":"2026-05-08T10:00:00+00:00","page_url":"https://stenobird.com/podcast/neuro-oncology-the-podcast-1565653/snobound-career-description-and-advice-from-dr-ryan-cecchi-in-neuropathology","url":"https://soc-neuro-onc.libsyn.com/snobound-career-description-and-advice-from-dr-ryan-cecchi-in-neuropathology","duration_seconds":1175,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/neuro-oncology-the-podcast-1565653/episodes/snobound-career-description-and-advice-from-dr-ryan-cecchi-in-neuropathology/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/neuro-oncology-the-podcast-1565653/snobound-career-description-and-advice-from-dr-ryan-cecchi-in-neuropathology.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"CATNON Conclusion: Closure on concurrent chemotherapy in IDHmt Grade 3 Astrocytoma","slug":"catnon-conclusion-closure-on-concurrent-chemotherapy-in-idhmt-grade-3-astrocytoma","published_at":"2026-05-04T10:00:00+00:00","page_url":"https://stenobird.com/podcast/neuro-oncology-the-podcast-1565653/catnon-conclusion-closure-on-concurrent-chemotherapy-in-idhmt-grade-3-astrocytoma","url":"https://soc-neuro-onc.libsyn.com/catnon-conclusion-closure-on-concurrent-chemotherapy-in-idhmt-grade-3-astrocytoma","duration_seconds":1653,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/neuro-oncology-the-podcast-1565653/episodes/catnon-conclusion-closure-on-concurrent-chemotherapy-in-idhmt-grade-3-astrocytoma/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/neuro-oncology-the-podcast-1565653/catnon-conclusion-closure-on-concurrent-chemotherapy-in-idhmt-grade-3-astrocytoma.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Hot Topics: What's next in neuro-oncology","slug":"hot-topics-what-s-next-in-neuro-oncology","published_at":"2026-05-01T10:00:00+00:00","page_url":"https://stenobird.com/podcast/neuro-oncology-the-podcast-1565653/hot-topics-what-s-next-in-neuro-oncology","url":"https://soc-neuro-onc.libsyn.com/hot-topics-whats-next-in-neuro-oncology","duration_seconds":1008,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/neuro-oncology-the-podcast-1565653/episodes/hot-topics-what-s-next-in-neuro-oncology/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/neuro-oncology-the-podcast-1565653/hot-topics-what-s-next-in-neuro-oncology.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Neuro-Oncology Nugget: Career Development Outreach from SNO","slug":"neuro-oncology-nugget-career-development-outreach-from-sno","published_at":"2026-04-27T10:00:00+00:00","page_url":"https://stenobird.com/podcast/neuro-oncology-the-podcast-1565653/neuro-oncology-nugget-career-development-outreach-from-sno","url":"https://soc-neuro-onc.libsyn.com/neuro-oncology-nugget-career-development-outreach-from-sno","duration_seconds":191,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/neuro-oncology-the-podcast-1565653/episodes/neuro-oncology-nugget-career-development-outreach-from-sno/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/neuro-oncology-the-podcast-1565653/neuro-oncology-nugget-career-development-outreach-from-sno.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Neuro-onc Narratives: An Interview with Caroline Catlin","slug":"neuro-onc-narratives-an-interview-with-caroline-catlin","published_at":"2026-04-24T10:00:00+00:00","page_url":"https://stenobird.com/podcast/neuro-oncology-the-podcast-1565653/neuro-onc-narratives-an-interview-with-caroline-catlin","url":"https://soc-neuro-onc.libsyn.com/neuro-onc-narratives-an-interview-with-caroline-catlin","duration_seconds":2286,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/neuro-oncology-the-podcast-1565653/episodes/neuro-onc-narratives-an-interview-with-caroline-catlin/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/neuro-oncology-the-podcast-1565653/neuro-onc-narratives-an-interview-with-caroline-catlin.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Author Interview:  \"DNA copy number patterns reveal prognostic markers and elucidate mechanisms of evolution in IDH-mutant astrocytoma\"","slug":"author-interview-dna-copy-number-patterns-reveal-prognostic-markers-and-elucidate-mechanisms-of-evolution-in-idh-mutant-astrocytoma","published_at":"2026-04-20T10:00:00+00:00","page_url":"https://stenobird.com/podcast/neuro-oncology-the-podcast-1565653/author-interview-dna-copy-number-patterns-reveal-prognostic-markers-and-elucidate-mechanisms-of-evolution-in-idh-mutant-astrocytoma","url":"https://soc-neuro-onc.libsyn.com/author-interview-dna-copy-number-patterns-reveal-prognostic-markers-and-elucidate-mechanisms-of-evolution-in-idh-mutant-astrocytoma","duration_seconds":2116,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/neuro-oncology-the-podcast-1565653/episodes/author-interview-dna-copy-number-patterns-reveal-prognostic-markers-and-elucidate-mechanisms-of-evolution-in-idh-mutant-astrocytoma/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/neuro-oncology-the-podcast-1565653/author-interview-dna-copy-number-patterns-reveal-prognostic-markers-and-elucidate-mechanisms-of-evolution-in-idh-mutant-astrocytoma.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Hot Topics: AYA in Neuro-Oncology","slug":"hot-topics-aya-in-neuro-oncology","published_at":"2026-04-17T10:00:00+00:00","page_url":"https://stenobird.com/podcast/neuro-oncology-the-podcast-1565653/hot-topics-aya-in-neuro-oncology","url":"https://soc-neuro-onc.libsyn.com/hot-topics-aya-in-neuro-oncology","duration_seconds":1903,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/neuro-oncology-the-podcast-1565653/episodes/hot-topics-aya-in-neuro-oncology/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/neuro-oncology-the-podcast-1565653/hot-topics-aya-in-neuro-oncology.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Neuro-Oncology Nugget: Bivalent EGFR/IL13Rα2 CAR T Cells for Recurrent Glioblastoma","slug":"neuro-oncology-nugget-bivalent-egfr-il13r-2-car-t-cells-for-recurrent-glioblastoma","published_at":"2026-04-13T10:00:00+00:00","page_url":"https://stenobird.com/podcast/neuro-oncology-the-podcast-1565653/neuro-oncology-nugget-bivalent-egfr-il13r-2-car-t-cells-for-recurrent-glioblastoma","url":"https://soc-neuro-onc.libsyn.com/neuro-oncology-nugget-bivalent-egfril13r2-car-t-cells-for-recurrent-glioblastoma","duration_seconds":149,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/neuro-oncology-the-podcast-1565653/episodes/neuro-oncology-nugget-bivalent-egfr-il13r-2-car-t-cells-for-recurrent-glioblastoma/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/neuro-oncology-the-podcast-1565653/neuro-oncology-nugget-bivalent-egfr-il13r-2-car-t-cells-for-recurrent-glioblastoma.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"SNObound: Career Advice from Dr. Brooke Braman in Radiation Oncology","slug":"snobound-career-advice-from-dr-brooke-braman-in-radiation-oncology","published_at":"2026-04-10T10:00:00+00:00","page_url":"https://stenobird.com/podcast/neuro-oncology-the-podcast-1565653/snobound-career-advice-from-dr-brooke-braman-in-radiation-oncology","url":"https://soc-neuro-onc.libsyn.com/snobound-career-advice-from-dr-brooke-braman-in-radiation-oncology","duration_seconds":1384,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/neuro-oncology-the-podcast-1565653/episodes/snobound-career-advice-from-dr-brooke-braman-in-radiation-oncology/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/neuro-oncology-the-podcast-1565653/snobound-career-advice-from-dr-brooke-braman-in-radiation-oncology.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Author Interview: Global analysis of clinical trials for children and adolescents with CNS tumors","slug":"author-interview-global-analysis-of-clinical-trials-for-children-and-adolescents-with-cns-tumors","published_at":"2026-04-06T10:00:00+00:00","page_url":"https://stenobird.com/podcast/neuro-oncology-the-podcast-1565653/author-interview-global-analysis-of-clinical-trials-for-children-and-adolescents-with-cns-tumors","url":"https://soc-neuro-onc.libsyn.com/global-analysis-of-clinical-trials-for-children-and-adolescents-with-cns-tumors","duration_seconds":1241,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/neuro-oncology-the-podcast-1565653/episodes/author-interview-global-analysis-of-clinical-trials-for-children-and-adolescents-with-cns-tumors/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/neuro-oncology-the-podcast-1565653/author-interview-global-analysis-of-clinical-trials-for-children-and-adolescents-with-cns-tumors.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Neuro-Oncology Nugget: Intracerebroventricular B7-H3 CAR T Cells for DIPG","slug":"neuro-oncology-nugget-intracerebroventricular-b7-h3-car-t-cells-for-dipg","published_at":"2026-03-23T16:00:00+00:00","page_url":"https://stenobird.com/podcast/neuro-oncology-the-podcast-1565653/neuro-oncology-nugget-intracerebroventricular-b7-h3-car-t-cells-for-dipg","url":"https://soc-neuro-onc.libsyn.com/neuro-oncology-nugget-intracerebroventricular-b7-h3-car-t-cells-for-dipg","duration_seconds":172,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/neuro-oncology-the-podcast-1565653/episodes/neuro-oncology-nugget-intracerebroventricular-b7-h3-car-t-cells-for-dipg/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/neuro-oncology-the-podcast-1565653/neuro-oncology-nugget-intracerebroventricular-b7-h3-car-t-cells-for-dipg.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Neuro-onc Narratives: Advocating for patient well-being in neuro-oncology","slug":"neuro-onc-narratives-advocating-for-patient-well-being-in-neuro-oncology","published_at":"2026-03-20T10:00:00+00:00","page_url":"https://stenobird.com/podcast/neuro-oncology-the-podcast-1565653/neuro-onc-narratives-advocating-for-patient-well-being-in-neuro-oncology","url":"https://soc-neuro-onc.libsyn.com/neuro-onc-narratives-advocating-for-patient-well-being-in-neuro-oncology-drs-ashlee-loughan-and-sarah-braun","duration_seconds":2570,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/neuro-oncology-the-podcast-1565653/episodes/neuro-onc-narratives-advocating-for-patient-well-being-in-neuro-oncology/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/neuro-oncology-the-podcast-1565653/neuro-onc-narratives-advocating-for-patient-well-being-in-neuro-oncology.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Author Interview: Visual morbidity, long-term outcome, and prognostic factors in infants and young children with optic pathway low-grade glioma","slug":"author-interview-visual-morbidity-long-term-outcome-and-prognostic-factors-in-infants-and-young-children-with-optic-pathway-low-grade-glioma","published_at":"2026-03-16T10:00:00+00:00","page_url":"https://stenobird.com/podcast/neuro-oncology-the-podcast-1565653/author-interview-visual-morbidity-long-term-outcome-and-prognostic-factors-in-infants-and-young-children-with-optic-pathway-low-grade-glioma","url":"https://soc-neuro-onc.libsyn.com/author-interview-visual-morbidity-long-term-outcome-and-pronostic-factors-in-infants-and-young-children-with-optic-pathway-low-grade-glioma","duration_seconds":1053,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/neuro-oncology-the-podcast-1565653/episodes/author-interview-visual-morbidity-long-term-outcome-and-prognostic-factors-in-infants-and-young-children-with-optic-pathway-low-grade-glioma/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/neuro-oncology-the-podcast-1565653/author-interview-visual-morbidity-long-term-outcome-and-prognostic-factors-in-infants-and-young-children-with-optic-pathway-low-grade-glioma.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Hot Topics: Clinician-Patient Relationship in Neuro-Oncology","slug":"hot-topics-clinician-patient-relationship-in-neuro-oncology","published_at":"2026-03-13T10:00:00+00:00","page_url":"https://stenobird.com/podcast/neuro-oncology-the-podcast-1565653/hot-topics-clinician-patient-relationship-in-neuro-oncology","url":"https://soc-neuro-onc.libsyn.com/hot-topics-clinician-patient-relationship-in-neuro-oncology","duration_seconds":1729,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/neuro-oncology-the-podcast-1565653/episodes/hot-topics-clinician-patient-relationship-in-neuro-oncology/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/neuro-oncology-the-podcast-1565653/hot-topics-clinician-patient-relationship-in-neuro-oncology.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Neuro-Oncology Nugget: Targeted Radiotherapy Using Rhenium-186 Nanoliposomes for Recurrent Glioma","slug":"neuro-oncology-nugget-targeted-radiotherapy-using-rhenium-186-nanoliposomes-for-recurrent-glioma","published_at":"2026-03-09T10:00:00+00:00","page_url":"https://stenobird.com/podcast/neuro-oncology-the-podcast-1565653/neuro-oncology-nugget-targeted-radiotherapy-using-rhenium-186-nanoliposomes-for-recurrent-glioma","url":"https://soc-neuro-onc.libsyn.com/neuro-oncology-nugget-targeted-radiotherapy-using-rhenium-186-nanoliposomes-for-recurrent-glioma","duration_seconds":210,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/neuro-oncology-the-podcast-1565653/episodes/neuro-oncology-nugget-targeted-radiotherapy-using-rhenium-186-nanoliposomes-for-recurrent-glioma/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/neuro-oncology-the-podcast-1565653/neuro-oncology-nugget-targeted-radiotherapy-using-rhenium-186-nanoliposomes-for-recurrent-glioma.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"SNObound: Career Advice from Dr. Gelareh Zadeh","slug":"snobound-career-advice-from-dr-gelareh-zadeh","published_at":"2026-03-06T11:00:00+00:00","page_url":"https://stenobird.com/podcast/neuro-oncology-the-podcast-1565653/snobound-career-advice-from-dr-gelareh-zadeh","url":"https://soc-neuro-onc.libsyn.com/snobound-dr-gelareh-zadeh","duration_seconds":1866,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/neuro-oncology-the-podcast-1565653/episodes/snobound-career-advice-from-dr-gelareh-zadeh/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/neuro-oncology-the-podcast-1565653/snobound-career-advice-from-dr-gelareh-zadeh.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Author Interview: Ibrutinib for newly diagnosed primary CNS lymphoma","slug":"author-interview-ibrutinib-for-newly-diagnosed-primary-cns-lymphoma","published_at":"2026-03-02T11:00:00+00:00","page_url":"https://stenobird.com/podcast/neuro-oncology-the-podcast-1565653/author-interview-ibrutinib-for-newly-diagnosed-primary-cns-lymphoma","url":"https://soc-neuro-onc.libsyn.com/author-interview-ibrutinib-for-newly-diagnosed-primary-cns-lymphoma","duration_seconds":1247,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/neuro-oncology-the-podcast-1565653/episodes/author-interview-ibrutinib-for-newly-diagnosed-primary-cns-lymphoma/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/neuro-oncology-the-podcast-1565653/author-interview-ibrutinib-for-newly-diagnosed-primary-cns-lymphoma.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}]}